Skip to content
Valneva
About Us
About Us
Advancing vaccines for better lives
Learn More
Our Strategy
Our Responsibility
Our Team
Products
Products
Focusing on vaccines for infectious diseases with high unmet needs.
Learn More
Japanese Encephalitis Vaccine
Cholera Vaccine
Marketing and Distribution
Manufacturing and Services
R&D
R&D
Dedicated to innovation in vaccine research and development.
Learn More
Pipeline
Lyme Disease – VLA15
Chikungunya – VLA1553
Zika – VLA1601
Clostridium Difficile – VLA84
Investors
Investors
Unlocking value for our shareholders
Learn More
Events and Presentations
Calendar
Corporate Presentations
Videos and Webcasts
Financial Reports
Stock Information
Stock Price
Analysts
Shareholder Structure
Vienna Stock Exchange Delisting
Corporate Governance
Corporate Compliance & Ethics
Regulated Information
Annual General Meeting
Contact
Media
Media
Press releases, latest news and media resources
Learn More
Press Releases
In The News
Scientific Publications
Media Kit
Media Contact
Careers
Contact
EN
FR
Search
Search for:
In The News
July 9, 2018
Wall Street Journal
New Effort for Lyme Disease Vaccines Draws Early Fire
July 5, 2018
NBC News Center Maine
New Lyme vaccine being fast-tracked by FDA
July 2, 2018
Outbreak News Today
Lyme disease vaccine update: ‘Significant progress’ being made
June 11, 2018
Gear Junkie
Lyme Disease Vaccine Inches Closer to Reality
1
2
3
4